Stock doesn't offer attractive dividend returns
Not a good time to invest, stock is in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Sanjivani Paranteral is engaged in the business of pharmaceutical products.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has increased by 2.72%
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant